Antiviral activity of indole derivatives. 2009

Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
Department of Pharmaceutical Sciences, University of Genoa, Genoa, Italy.

Unsymmetrical methylene derivatives 5 were prepared following a known method, by reaction of the Mannich bases of 2-naphthols 4 with indoles. All synthesized compounds were tested against a wide panel of viruses, since previous work showed that Mannich bases on 7-hydroxycoumarin 1 and unsymmetrical methylene derivatives 2 were endowed with some antiviral activities. The symmetrical Mannich bases 4 were completely inactive, whereas the unsymmetrical methylene derivatives 5, although possessing a certain degree of toxicity, showed a significant activity against RSV. Some of compounds 5 showed a moderate antiviral activity against HIV-1, BVDV, YFV and CVB-2. The lack of activity of Mannich bases 4 demonstrates the crucial importance for antiviral activity of coumarin moiety present in Mannich bases 1.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D012136 Respiratory Syncytial Viruses A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported. Chimpanzee Coryza Agent,Orthopneumovirus,RSV Respiratory Syncytial Virus,Chimpanzee Coryza Agents,Coryza Agent, Chimpanzee,Orthopneumoviruses,Respiratory Syncytial Virus,Syncytial Virus, Respiratory,Virus, Respiratory Syncytial
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004770 Enterovirus A genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated "human enterovirus". Coxsackie Viruses,Coxsackieviruses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015005 Yellow fever virus The type species of the FLAVIVIRUS genus. Principal vector transmission to humans is by AEDES spp. mosquitoes.
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
August 2014, Acta pharmaceutica Sinica. B,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
April 2010, Bioorganic & medicinal chemistry,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
June 1968, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
September 1958, Plant physiology,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
August 2008, Journal of medicinal chemistry,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
January 1972, Medycyna doswiadczalna i mikrobiologia,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
July 1978, Acta virologica,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
January 2008, Zeitschrift fur Naturforschung. C, Journal of biosciences,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
January 2019, Monatshefte fur chemie,
Michele Giampieri, and Alessandro Balbi, and Mauro Mazzei, and Paolo La Colla, and Cristina Ibba, and Roberta Loddo
October 1970, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!